VERACYTE, INC. (21)

Browse by Contract Category

Contracts

Form of stock unit award agreement (Filed With SEC on November 2, 2020)
Offer Letter dated as of August 9, 2011 with John Hanna (Filed With SEC on February 25, 2020)
Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between John Hanna and the Registrant (Filed With SEC on July 30, 2019)
Diagnostic Development Agreement, dated December 28, 2018, between Johnson & Johnson Services, Inc. and the Registrant (Filed With SEC on February 25, 2019)
Form of stock option award agreement (Filed With SEC on November 2, 2020)
Underwriting Agreement dated August 4, 2020 (Filed With SEC on August 5, 2020)
Enrollment Form for the Amended and Restated Employee Stock Purchase Plan (Filed With SEC on July 30, 2020)
Amended and Restated Employee Stock Purchase Plan (Filed With SEC on June 9, 2020)
Offer Letter dated as of March 5, 2008 with Giulia Kennedy (Filed With SEC on February 25, 2020)
Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on February 25, 2020)
Registration Rights Schedule, dated December 3, 2019 (Filed With SEC on December 3, 2019)
License and Asset Purchase Agreement, dated December 3, 2019, by and among Veracyte, Inc. and NanoString, Inc (Filed With SEC on December 3, 2019)
Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between Giulia Kennedy and the Registrant (Filed With SEC on July 30, 2019)
Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between Keith Kennedy and the Registrant (Filed With SEC on July 30, 2019)
Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between Bonnie Anderson and the Registrant (Filed With SEC on July 30, 2019)
Services and Separation Agreement, effective April 22, 2019 between Chris Hall and the Registrant (Filed With SEC on July 30, 2019)
Underwriting Agreement dated May 2, 2019 (Filed With SEC on May 3, 2019)
Agreement dated as of October 16, 2017, between Thyroid Cytopathology Partners, P.A. and the Registrant, as amended (Filed With SEC on April 30, 2019)
Amended and Restated Change in Control and Severance Agreement, effective October 23, 2018 between Keith Kennedy and the Registrant (Filed With SEC on February 25, 2019)
Amended and Restated Change in Control and Severance Agreement, effective October 23, 2018 between Christopher Hall and the Registrant (Filed With SEC on February 25, 2019)
Amended and Restated Change in Control and Severance Agreement, effective October 23, 2018 between Bonnie Anderson and the Registrant (Filed With SEC on February 25, 2019)